Dental Treatment Approach Under General Anesthesia for a Patient with Rare Nemaline Myopathy: A Case Report

Abstract

Nemaline myopathy is a rare congenital disorder affecting skeletal muscles. Nemaline myopathy presents symptoms such as muscle weakness, hypotonia, and functional impairments that often become apparent in infancy or early childhood. In addition to motor difficulties, patients with nemaline myopathy frequently encounter significant oral health challenges, including an increased risk of dental care, malocclusion, and gingival infections. The reasons for these problems are impaired chewing function, excessive salivary flow, and structural anomalies in the oral cavity. These issues, combined with the possibility of systemic complications such as cardiac anomalies and respiratory problems, necessitate specialized medical and dental care. This report describes the dental treatment of a 3.5-year-old child diagnosed with nemaline myopathy, who presented with severe dental decay and associated complications necessitating comprehensive care under general anesthesia. Due to the patient’s inability to tolerate in-office procedures and risks such as malignant hyperthermia, treatment was carefully planned within a hospital setting, involving extractions, restorations, and preventive measures. Preoperative assessments and a multidisciplinary approach ensured both safety and effectiveness in managing the child’s complex needs. This case emphasizes the importance of tailored dental care and collaborative management for patients with rare neuromuscular disorders. It offers guidance for addressing their unique challenges while prioritizing safety during treatment under general anesthesia.

Keywords

• Nemaline myopathy
• gneral anesthesia in dentistry
• Special Health Care Needs Dentistry
• dentalmanagement of rare disorders
• multidisciplinary approach in dentistry

References

1. 1. Mallineni SK, Yiu CKY. Dental treatment under general anesthesia for special-needs patients: analysis of the literature. J Investig Clin Dent 2016;7(4):325–31.
2. 2. Malamed S. Sedation: a guide to patient management. 4th ed. St. Louis: Mosby; 2003:428–31.
3. 3. Christophers B, Lopez MA, Gupta VA, Vogel H, Baylies M. Pediatric Nemaline Myopathy: A Systematic Review Using Individual Patient Data. J Child Neurol 2022;37(7):652–63.
4. 4. Badnaware S, Gupta P. A Rare Case Report of Dental and Craniofacial Manifestations of Nemaline Myopathy. Cureus 2023;15(11):49091.
5. 5. Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 2007;22(8):1027–49.
6. 6. Xue Y, Magoulas PL, Wirthlin JO, Buchanan EP. Craniofacial Manifestations in Severe Nemaline Myopathy. J Craniofac Surg 2017;28(3):258–60.
7. 7. Ennis J, Dyment DA, Michaud J, McMillan HJ. Congenital Nemaline Myopathy: The Value of Magnetic Resonance Imaging of Muscle. Can J Neurol Sci 2015;42(5):338–40.
8. 8. American Academy of Pediatric Dentistry. Policy for selecting anesthesia providers for the delivery of office-based deep sedation/general anesthesia. The Reference Manual of Pediatric Dentistry. Chicago, Ill.: American Academy of Pediatric Dentistry; 2024:170-2.

9. 9. Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis 2015;10:93.
10. 10. Dougherty N. The dental patient with special needs: a review of indications for treatment under general anesthesia. Spec Care Dentist 2009;29(1):17–20.
11. 11. Schieren M, Defosse J, Böhmer A, Wappler F, Gerbershagen MU. Anaesthetic management of patients with myopathies. European Journal of Anaesthesiology| EJA. 2017;34(10):641–9.
12. 12. Tran N, Smith D. Anesthetic consideration for patients with nemaline rod myopathy: a literature review. Pediatric Anesthesia & Critical Care Journal (PACCJ). 2017;5(1).
13. 13. Hopkins P. Malignant hyperthermia: pharmacology of triggering. British journal of anaesthesia. 2011;107(1):48–56.
14. 14. Klingler W, Lehmann-Horn F, Jurkat-Rott K. Complications of anaesthesia in neuromuscular disorders. Neuromuscular disorders. 2005;15(3):195–206.